BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Synthetic Biologics, Inc. 

3930 Varsity Drive

Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-332-7800 Fax: 734-332-7878


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Synthetic Biologics, Inc. (SYN) Safe-To-Proceed Under IND To Initiate Clinical Trials Of SYN-004 For The Prevention C. Difficile Infection 11/24/2014 9:47:31 AM
Synthetic Biologics, Inc. (SYN) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014 8:04:40 AM
Synthetic Biologics, Inc. (SYN) To Report Third Quarter 2014 Financial Results 11/6/2014 8:05:48 AM
Synthetic Biologics, Inc. (SYN) Announces Allowance Of Key U.S. Composition Of Matter Patent For C. Difficile Program 10/22/2014 8:18:47 AM
Synthetic Biologics, Inc. (SYN) Appoints Prominent Gastrointestinal (GI) Key Opinion Leaders To Irritable Bowel Syndrome (IBS) Clinical Advisory Board 10/15/2014 8:09:40 AM
Synthetic Biologics, Inc. (SYN) To Raise $20.7 Million In Registered Direct Offering 10/10/2014 7:52:06 AM
Synthetic Biologics, Inc. (SYN)' Statin-Class Candidate For Constipation-Predominant Irritable Bowel Syndrome Detailed At Company's Investor Day 9/16/2014 10:07:15 AM
Synthetic Biologics, Inc. (SYN) Receives Orphan Drug Designation For SYN-005 Treatment For Whooping Cough (Pertussis) 9/12/2014 11:32:36 AM
Synthetic Biologics, Inc. (SYN) To Host Phase 2 Trimesta™ For Multiple Sclerosis Conference Call 9/11/2014 8:17:07 AM
Synthetic Biologics, Inc. (SYN) To Webcast September 16, 2014 Irritable Bowel Syndrome (IBS) Investor Day 9/10/2014 11:58:37 AM
12345678910...